159 related articles for article (PubMed ID: 11552898)
1. H2-receptor antagonists in the treatment of functional (nonulcer) dyspepsia: a meta-analysis of randomized controlled clinical trials.
Redstone HA; Barrowman N; Veldhuyzen Van Zanten SJ
Aliment Pharmacol Ther; 2001 Sep; 15(9):1291-9. PubMed ID: 11552898
[TBL] [Abstract][Full Text] [Related]
2. Treatment of non-ulcer dyspepsia: a meta-analysis of placebo-controlled prospective studies.
Allescher HD; Böckenhoff A; Knapp G; Wienbeck M; Hartung J
Scand J Gastroenterol; 2001 Sep; 36(9):934-41. PubMed ID: 11521983
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological interventions for non-ulcer dyspepsia.
Moayyedi P; Soo S; Deeks J; Delaney B; Innes M; Forman D
Cochrane Database Syst Rev; 2003; (1):CD001960. PubMed ID: 12535421
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological interventions for non-ulcer dyspepsia.
Moayyedi P; Soo S; Deeks J; Delaney B; Innes M; Forman D
Cochrane Database Syst Rev; 2004 Oct; (4):CD001960. PubMed ID: 15495023
[TBL] [Abstract][Full Text] [Related]
5. Histamine H2-receptor antagonists for urticaria.
Fedorowicz Z; van Zuuren EJ; Hu N
Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD008596. PubMed ID: 22419335
[TBL] [Abstract][Full Text] [Related]
6. Histamine H2 antagonists for functional dyspepsia: A protocol for a systematic review and meta-analysis.
Li J; Wang F; Lv L; Xu L; Zeng E; Tang X
Medicine (Baltimore); 2019 Nov; 98(47):e18128. PubMed ID: 31764854
[TBL] [Abstract][Full Text] [Related]
7. H(2) receptor antagonists and prokinetics in dyspepsia: a critical review.
Bytzer P
Gut; 2002 May; 50 Suppl 4(Suppl 4):iv58-62. PubMed ID: 11953351
[TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of the effect of omeprazole, cimetidine, famotidine and ranitidine on histamine induced cutaneous wheal and flare response.
Saha N; Sachdev A; Bhasin DK; Sankaranahyanan A; Khosla PP; Singh K; Sharma PL
Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):322-5. PubMed ID: 8103763
[TBL] [Abstract][Full Text] [Related]
9. Systematic review: Antacids, H2-receptor antagonists, prokinetics, bismuth and sucralfate therapy for non-ulcer dyspepsia.
Moayyedi P; Soo S; Deeks J; Forman D; Harris A; Innes M; Delaney B
Aliment Pharmacol Ther; 2003 May; 17(10):1215-27. PubMed ID: 12755835
[TBL] [Abstract][Full Text] [Related]
10. Ranitidine effectively relieves symptoms in a subset of patients with functional dyspepsia.
Farup PG; Wetterhus S; Osnes M; Ulshagen K
Scand J Gastroenterol; 1997 Aug; 32(8):755-9. PubMed ID: 9282965
[TBL] [Abstract][Full Text] [Related]
11. The management of acid-related dyspepsia in general practice: a comparison of an omeprazole versus an antacid-alginate/ranitidine management strategy. Compete Research Group [corrected].
Mason I; Millar LJ; Sheikh RR; Evans WM; Todd PL; Turbitt ML; Taylor MD
Aliment Pharmacol Ther; 1998 Mar; 12(3):263-71. PubMed ID: 9570261
[TBL] [Abstract][Full Text] [Related]
12. Maintenance therapy of duodenal ulcer with H2-receptor antagonists--a meta-analysis.
Palmer RH; Frank WO; Karlstadt R
Aliment Pharmacol Ther; 1990 Jun; 4(3):283-94. PubMed ID: 1983324
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effect of the antacid Rennie versus low-dose H2-receptor antagonists (ranitidine, famotidine) on intragastric acidity.
Netzer P; Brabetz-Höfliger A; Bründler R; Flogerzi B; Hüsler J; Halter F
Aliment Pharmacol Ther; 1998 Apr; 12(4):337-42. PubMed ID: 9690722
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis.
Veldhuyzen van Zanten SJ; Jones MJ; Verlinden M; Talley NJ
Am J Gastroenterol; 2001 Mar; 96(3):689-96. PubMed ID: 11280535
[TBL] [Abstract][Full Text] [Related]
15. Relief of epigastric pain in nonulcer dyspepsia: controlled trial of the promotility drug cisapride.
De Nutte N; Van Ganse W; Witterhulghe M; Defrance P
Clin Ther; 1989; 11(1):62-8. PubMed ID: 2655906
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological treatments for functional nausea and functional dyspepsia in children: a systematic review.
Browne PD; Nagelkerke SCJ; van Etten-Jamaludin FS; Benninga MA; Tabbers MM
Expert Rev Clin Pharmacol; 2018 Dec; 11(12):1195-1208. PubMed ID: 30360666
[TBL] [Abstract][Full Text] [Related]
17. Drug treatment of functional dyspepsia. A meta-analysis of randomized controlled clinical trials.
Dobrilla G; Comberlato M; Steele A; Vallaperta P
J Clin Gastroenterol; 1989 Apr; 11(2):169-77. PubMed ID: 2567747
[TBL] [Abstract][Full Text] [Related]
18. Use of histamine2-antagonists for the treatment of verruca vulgaris.
Fit KE; Williams PC
Ann Pharmacother; 2007 Jul; 41(7):1222-6. PubMed ID: 17535844
[TBL] [Abstract][Full Text] [Related]
19. Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study.
Armstrong D; Veldhuyzen van Zanten SJ; Barkun AN; Chiba N; Thomson AB; Smyth S; Sinclair P; Chakraborty B; White RJ;
Aliment Pharmacol Ther; 2005 May; 21(10):1189-202. PubMed ID: 15882239
[TBL] [Abstract][Full Text] [Related]
20. [Ranisan, 75 mg in the treatment of patients with the functional dyspepsia syndrome].
Manushkin ON; Maslovskiĭ LV; Shuleshova AG; Sazonova II; Anikina NIu
Eksp Klin Gastroenterol; 2005; (5):53-5. PubMed ID: 16518916
[No Abstract] [Full Text] [Related]
[Next] [New Search]
